Position in BMY
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$13,710,296
+$2,906,924 QoQ
Shares Held
226,056
+12.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. BMY ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
226,056 | $13,710,296 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,710,296 | 226,056 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $10,803,372 | 200,285 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $6,609,450 | 146,551 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $8,428,066 | 182,071 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,590,295 | 190,036 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,508,414 | 168,112 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,280,521 | 160,041 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,409,952 | 274,740 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $6,820,344 | 125,767 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,345,302 | 123,666 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $11,320,876 | 195,053 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,662,583 | 229,282 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $44,580,607 | 643,206 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $43,613,283 | 606,161 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $38,364,002 | 539,654 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,093,388 | 170,044 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $12,074,488 | 165,336 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,727,066 | 107,892 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $3,073,525 | 51,944 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $3,541,192 | 52,996 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $3,276,447 | 51,900 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $3,015,092 | 48,607 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $5,386,911 | 89,350 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $6,363,630 | 108,225 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $4,996,700 | 89,643 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||